Adhera Therapeutics, Inc.
CIK 737207 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adhera Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jan 30, 2024 | SEC STAFF ACTION | 9999999997-24-000226 |
| Jan 18, 2024 | 8-K | 0001493152-24-002907 |
| Jan 16, 2024 | 8-K | 0001493152-24-002422 |
| Nov 29, 2023 | 8-K | 0001493152-23-043045 |
| Nov 20, 2023 | 10-Q | 0001493152-23-042138 |
| Nov 15, 2023 | NT 10-Q | 0001493152-23-041510 |
| Oct 12, 2023 | 8-K | 0001493152-23-037063 |
| Aug 21, 2023 | 10-Q | 0001493152-23-029594 |
| Aug 15, 2023 | NT 10-Q | 0001493152-23-028965 |
| Jun 29, 2023 | 8-K | 0001493152-23-022945 |
| May 22, 2023 | 10-Q | 0001493152-23-018516 |
| May 15, 2023 | NT 10-Q | 0001493152-23-017374 |
| May 5, 2023 | 8-K | 0001493152-23-015579 |
| May 4, 2023 | 8-K | 0001493152-23-015429 |
| May 2, 2023 | 10-K/A | 0001493152-23-015188 |
| Mar 31, 2023 | 10-K | 0001493152-23-010160 |
| Mar 8, 2023 | 8-K | 0001493152-23-007008 |
| Feb 23, 2023 | 8-K | 0001493152-23-005889 |
| Jan 26, 2023 | 8-K | 0001493152-23-002592 |
| Dec 2, 2022 | S-1 | 0001493152-22-034344 |
| Nov 22, 2022 | 8-K | 0001493152-22-033276 |
| Nov 14, 2022 | 10-Q | 0001493152-22-031940 |
| Nov 9, 2022 | 8-K | 0001493152-22-031159 |
| Oct 6, 2022 | 8-K | 0001493152-22-027804 |
| Sep 9, 2022 | 8-K | 0001493152-22-025495 |